story of the week
T-Cell–Redirecting GPRC5D Bispecific Antibody Talquetamab for Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
N. Engl. J. Med 2022 Dec 15;387(24)2232-2244, A Chari, MC Minnema, JG Berdeja, A Oriol, NWCJ van de Donk, P Rodríguez-Otero, E Askari, MV Mateos, LJ Costa, J Caers, R Verona, S Girgis, S Yang, RB Goldsmith, X Yao, K Pillarisetti, BW Hilder, J Russell, JD Goldberg, A KrishnanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.